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Hematopoietic progenitor cells progress through 
pathways that restrict developmental plasticity 
and enforce commitment to specific lineages 
(Laiosa  et  al.,  2006;  Brown  et  al.,  2007). 
These processes coincide with gene expression 
remodeling as orchestrated by a transcription 
factor network (Laiosa et al., 2006; Nutt and 
Kee,  2007).  Many  DNA-binding  compo-
nents  of  this  network  are  known,  but  how 
these proteins coordinately regulate gene ex-
pression is poorly understood. Also, disruption 
of the hematopoietic transcription factor net-
work is strongly associated with oncogenesis   
(O’Neil  and  Look,  2007;  Rosenbauer  and   
Tenen,  2007).  Thus,  further  characterizing 
the  mechanisms  that  control  hematopoiesis 
could provide insights regarding neoplasia in 
this system.
Among hematopoietic developmental path-
ways, B lymphopoiesis is well defined (Hardy   
et al., 2007; Welner et al., 2008). During this 
process, the transcription factors Ikaros, E2A, 
EBF, and Pax5 likely function to recruit protein 
complexes that activate B-lineage genes or re-
press genes associated with other lineages (Ng   
et al., 2007; Nutt and Kee, 2007). Consistent 
with this idea, gene activation by EBF and Pax5 
involves  the  chromatin-remodeling  complex 
SWI–SNF, whereas Ikaros or Pax5 can interact 
with transcriptional corepressors (Eberhard et al., 
2000; Koipally and Georgopoulos, 2002; Gao 
et al., 2009). Interactions between B cell tran-
scription factors and unknown cofactors are   
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A recessive mutation named Justy was found that abolishes B lymphopoiesis but does not 
impair other major aspects of hematopoiesis. Transplantation experiments showed that 
homozygosity for Justy prevented hematopoietic progenitors from generating B cells but 
did not affect the ability of bone marrow stroma to support B lymphopoiesis. In bone 
marrow from mutant mice, common lymphoid progenitors and pre-pro–B cells appeared 
normal, but cells at subsequent stages of B lymphopoiesis were dramatically reduced in 
number. Under culture conditions that promoted B lymphopoiesis, mutant pre-pro–B cells 
remained alive and began expressing the B cell marker CD19 but failed to proliferate.  
In contrast, these cells were able to generate myeloid or T/NK precursors. Genetic and  
molecular analysis demonstrated that Justy is a point mutation within the Gon4-like 
(Gon4l) gene, which encodes a protein with homology to transcriptional regulators.  
This mutation was found to disrupt Gon4l pre-mRNA splicing and dramatically reduce 
expression of wild-type Gon4l RNA and protein. Consistent with a role for Gon4l in tran-
scriptional regulation, the levels of RNA encoding C/EBP and PU.1 were abnormally high 
in mutant B cell progenitors. Our findings indicate that the Gon4l protein is required for  
B lymphopoiesis and may function to regulate gene expression during this process.
© 2010 Lu et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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F1 males were screened by flow cytometry to identify mice 
with normal peripheral blood that might be carriers of reces-
sive mutations. These mice were mated to wild-type C3H fe-
males and then to the resulting F2 females. Flow cytometric 
analysis identified F3 mice that lacked blood cells expressing 
the B-lineage marker CD45R/B220 (B220). These mice were 
crossed to wild-type C3H mice, and the progeny were used 
for brother–sister matings. Offspring lacking B220+ cells were 
crossed to wild-type C3H mice, and the progeny were used 
for brother–sister matings to recover mice that were homozy-
gous for the causal mutation. These mice are fertile and have a 
normal life span but lack serum immunoglobulin and fail to 
generate antibodies when challenged with antigens (unpub-
lished data). The mutant strain was named Justy (just T cells). 
In the text that follows, mice homozygous for the mutation are 
called Justy mice.
Spleens from Justy mice were abnormally small, had hypo-
plastic white pulp, and yielded significantly fewer cells than 
wild-type organs (Fig. 1, a and b). Flow cytometric analysis 
showed that the frequency and number of CD19+ cells in 
Justy spleens were dramatically decreased (Fig. 1, c and d) and 
that lymph nodes or peritoneal lavages from Justy mice lacked 
CD19+ cells (not depicted). T and NK cell populations were 
characterized  by  flow  cytometry  (unpublished  data).  The 
number of CD3+ cells in Justy spleens was consistently de-
creased by approximately twofold, but otherwise no abnormali-
ties affecting T cells were found. Likewise, NK cells in thymus 
and spleen appeared normal in Justy mice. The cellularity of 
also likely important for immunoglobulin gene rearrange-
ment (Fuxa et al., 2004; Reynaud et al., 2008). Thus, al-
though much has been defined, significant gaps remain in 
our knowledge of how gene expression is regulated during   
B lymphopoiesis.
Mice  bearing  random  mutations  are  powerful  tools  for 
identifying genes with roles in the immune system (Cook   
et al., 2006; Beutler et al., 2007). In this paper, we describe a 
chemically induced recessive mutation that blocks B lympho-
poiesis at an early stage without perturbing the development of 
other hematopoietic lineages. This lesion is a point mutation 
that  reduces  RNA  and  protein  expression  from  Gon4-like 
(Gon4l), which likely encodes a novel regulator of gene ex-
pression. The mutation had little impact on B-lineage gene 
expression but impaired the regulation of genes associated with 
myeloid cell development. Our findings demonstrate that Gon4l 
is critical for B lymphopoiesis.
RESULTS AND DISCUSSION
Justy mice lack peripheral B cells
Male C3HeB/FeJ (C3H) mice were injected with a dose of   
n-ethyl-n-nitrosourea that resulted in 1 mutation per 2.7   
megabase pairs of DNA (Hrabé de Angelis et al., 2000; Augustin   
et al., 2005) and were mated to wild-type C3H females. 
Figure 1.  Justy mice lack B cells. (a) Spleens and hematoxylin/eosin-
stained spleen sections (100× magnification). Bars: (left) 1 cm; (right) 225 µm. 
(b) Cell yields from wild-type and Justy spleens. (c) Flow cytometric analysis of 
splenocytes. (d) CD19+ cell yields from splenocyte preparations. (e) Leukocyte 
yields from bone marrow cell preparations. (f) Flow cytometric analysis of 
bone marrow cells. Horizontal bars in b, d, and e indicate mean cell count. 
Data in c and f are representative of five independent experiments.
Figure 2.  The Justy mutation intrinsically affects hematopoietic 
progenitors. (a and c) Diagrams of bone marrow transplants performed. 
(b) Flow cytometric analysis of bone marrow from a Justy mouse that 
received CD45.1+ wild-type bone marrow. (d) Flow cytometric analysis of 
bone marrow from a wild-type mouse that received CD45.2+ Justy bone 
marrow. Data in b and d are representative of two independent transplan-
tation experiments, each involving three recipients that received pooled 
bone marrow from two donors.JEM VOL. 207, July 5, 2010  1361
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cells failed to induce B lymphopoiesis from Justy cells. Justy 
bone marrow rescued hematopoiesis when transplanted into 
wild-type mice but donor-derived B220+IgM+ cells were not 
detected, indicating that wild-type stroma could not rescue   
B lymphopoiesis from Justy cells (Fig. 2, c and d). B220+IgM+ 
cells were detected in host-derived bone marrow, suggesting 
that Justy cells did not suppress B lymphopoiesis from wild 
type. Thus, the Justy mutation has an intrinsic effect on hema-
topoietic progenitors.
The Justy mutation blocks the generation  
of pro–B cells
Flow cytometric analysis was performed to define how Justy 
affects bone marrow. Because the Mac-1+Gr-1+ compart-
ment in Justy bone marrow is enlarged (Fig. 1 f; Fig. S1 a), 
myeloid progenitors were characterized. The frequency and 
total  number  of  cells  defined  as  myeloid/granulocytic/ 
erythroid progenitors (LinIL-7RSca-1c-Kit+ cells; Akashi 
et al., 2000) were consistently but modestly increased in Justy 
bone marrow relative to wild type (Fig. S1, b and c). Based 
on CD34 and FcR expression, these differences were a re-
sult of proportionate increases in the number of all progeni-
tors in the fraction (unpublished data). These alterations could 
reflect cell-intrinsic effects or may arise as a result of the void 
created from the absence of B cells (see following paragraph). 
The frequency and number of LSK (LinIL-7RaSca-1+c-
Kit+) cells in Justy bone marrow were normal (Fig. S1, b and d), 
suggesting that the multipotent stem cell pool is not grossly 
perturbed.
B cell progenitors were also examined. B220+CD43 cells 
comprising B and immature B cells were decreased 300-fold 
in Justy bone marrow relative to wild type (Fig. 3, a and b). 
However, the frequency and number of B220+CD43+ cells in 
Justy bone marrow were close to normal (Fig. 3, a and b). This 
population contains cells defined as pro–B and pre-pro–B cells 
but also includes NK cell precursors and plasmacytoid DCs 
(pDCs). To distinguish these subsets, expression of CD19, the 
NK marker CD49b (clone DX5), and the pDC markers CD11c 
and Ly6C by B220+CD43+ cells was assessed (Fig. 3 c). Rela-
tive to wild type, the frequency and number of pro–B cells 
(CD49bCD11cLy6CCD19+) in Justy bone marrow were 
greatly decreased, but these parameters were normal for pre-
pro–B cells (quadruple-negative cells; Fig. 3, c and d). Surface 
levels of IL-7 receptor  and AA4.1/CD93 on Justy pre-pro–
B cells were similar to that on wild type (Fig. 3 e). Common 
lymphoid progenitors (CLPs) are a primary source of B cell 
progenitors.  Therefore,  these  cells  were  also  characterized 
(Fig. S2 a). Markers examined included Ly6d, which identi-
fies CLPs with potent B cell potential (Inlay et al., 2009; 
Mansson et al., 2010). These studies demonstrated that the 
phenotype and number (Fig. S2 b) of CLPs in Justy bone mar-
row were normal.
Differential expression of BP-1 subdivides the pro–B cell 
compartment into late pro–B cells (HSAhiBP-1+) and early 
pro–B cells (HSAhiBP-1), whereas differential expression of 
CD24/HSA subdivides late pro–B cells into fractions C and C, 
Justy bone marrow was similar to that of wild type (Fig. 1 e), 
but the ratio between myeloid and lymphoid cells was in-
creased (Fig. 1 f), indicating that the mutation affects this ana-
tomical site.
The effect of the Justy mutation is intrinsic  
to hematopoietic progenitors
Reciprocal bone marrow transplants were performed to assess 
how the mutation affects hematopoietic progenitors and bone 
marrow stroma. Wild-type bone marrow restored hematopoi-
esis  when  transplanted  into  Justy  mice  and  donor-derived 
B220+IgM+ cells were detected in bone marrow (and spleen), 
indicating that Justy stroma can support B lymphopoiesis   
(Fig. 2, a and b). The few host-derived cells present lacked 
B220+IgM+ cells, suggesting that introduction of wild-type 
Figure 3.  B lymphopoiesis in Justy mice arrests at the early pro–B 
cell stage. (a) Flow cytometric analysis of bone marrow. The B220+CD43 
gate contains pre–B and immature B cells; the B220+CD43+ gate contains 
pre-pro–B and pro–B cells, NK cell precursors, and pDCs. (b) Yields of 
B220+CD43 and B220+CD43+ cells from bone marrow. (c) Flow cytomet-
ric analysis of B220+CD43+ cells (right gate in a). Pro–B cells are in the 
CD19+Ly6CCD11cCD49b gate; pre-pro–B cells are in the quadruple-
negative gate. (d) Yields of pro–B and pre-pro–B cells from bone marrow. 
(e) Flow cytometric analysis of pre-pro–B cells (from gate in c). (f) Flow 
cytometric analysis of pro–B cells (from gate in c). (g) Yields of early and 
late pro–B cells from bone marrow. Data in a, c, e, and f are representative 
of five independent experiments. Horizontal bars in b, d, and g indicate 
mean cell count.1362 Gon4l is required for B lymphopoiesis | Lu et al.
both produced B220Thy1.2+CD49b+ cells under conditions 
that promote T/NK cell precursor development (Fig. 4, e and f). 
Thus, Justy pre-pro–B cells retain the capacity to differentiate 
toward these alternative lineages.
The Justy mutation disrupts splicing of RNA transcribed 
from the Gon4l gene
To identify the genetic basis for the phenotype, C3H Justy 
mice were crossed to wild-type B6 mice and F1 progeny 
were interbred. Genomic DNA from F2 mice that lacked or 
contained B cells was screened with a panel of PCR primers 
that detect simple sequence length polymorphisms (SSLPs) 
between C3H and B6 and thus define the strain of origin for 
discrete genomic intervals. This analysis established a com-
plete association between a lack of B cells and a 617-kb-pair 
region on chromosome 3 from C3H between SSLPs D3Mit49 
and D3Mit175 (bps 88353984 and 88971024; University of 
California, Santa Cruz (UCSC) assembly, July 2007). The 
SSLPs were used to transfer the C3H segment into the B6 
background  via  serial  backcrossing.  Intercrossing  F10  B6 
mice generated offspring that were homozygous for the C3H 
region with Mendelian frequency. Flow cytometric analysis 
showed that B lymphopoiesis in these mice is blocked, as 
seen in the original mutant strain (unpublished data), con-
firming that the transferred C3H DNA segment contained 
the causative lesion.
The identified region encodes 13 genes (Fig. 5 a and   
Table S1). Quantitative (Q) RT-PCR analysis of RNA from 
bone marrow lineage-negative cells showed that all of these 
genes were expressed normally in Justy cells except for Gon4l, 
which was expressed at approximately twofold lower levels 
relative to wild type (Fig. 5 b). RT-PCR analysis was per-
formed to define the structure of Gon4l mRNA expressed in 
wild-type and Justy cells, which revealed a striking difference 
(Fig. 5 c). Primers targeting exons 24 and 26 amplified a 446-
bp product from wild-type cDNA with the expected se-
quence. The same product was amplified from Justy cDNA 
with the latter containing cells expressing pre–B cell receptors. 
Fraction C cells were absent from Justy bone marrow, but 
fraction C and early pro–B cells were detectable (Fig. 3 f). 
However, relative to wild type, the numbers of these cells 
were dramatically decreased (Fig. 3 g). These data demonstrate 
that B lymphopoiesis in Justy mice is disrupted starting at the 
early pro–B cell stage.
Justy B cell progenitors specifically lack B cell potential
Pre-pro–B cells, as defined in the previous section, can give 
rise to early pro–B cells in culture (Rumfelt et al., 2006). To 
assess how the mutation affects the developmental potential of 
pre-pro–B cells, these cells were sort purified from wild-type 
or Justy bone marrow and added to stromal cell monolayers 
under conditions that promote B lymphopoiesis. 10 d later, 
surface marker phenotypes and cell yields were assessed by 
flow cytometry (Fig. 4, a and c). Wild-type pre-pro–B cells 
proliferated extensively and gave rise to B220+CD19+ cells.   
In contrast, although Justy cells could generate B220+CD19+ 
cells, the yield was much lower compared with that from wild 
type. The responses of sort-purified early pro–B cells to these 
conditions were also assessed (Fig. 4, b and c). Wild-type cells 
underwent robust proliferation, as expected, whereas Justy cells 
remained alive, as judged by vital dye exclusion, but failed to 
expand. IL-7/Stat5 signaling drives B cell proliferation in the 
culture  system.  When  analyzed  immediately  after  removal 
from mice, similar levels of surface IL-7 receptor  and intra-
cellular tyrosine-phosphorylated Stat5 were detected in wild-
type and Justy B cell progenitors (Fig. 3 e; Fig. S3), suggesting 
that the mutation does not impair receptor-proximal IL-7 sig-
naling. These data indicate that the Justy mutation impairs the 
development of early pro–B cells from progenitors. Alternatively 
(or in addition), the mutation may prevent early pro–B cells 
that develop from responding to the appropriate stimuli.
Pre-pro–B cells can generate cells expressing myeloid or 
T/NK markers (Balciunaite et al., 2005; Rumfelt et al., 2006). 
Under conditions that favor B lymphopoiesis but permit myeloid 
cell development, wild-type and Justy pre-pro–B cells both 
generated cells expressing the macrophage/pDC marker Ly6C 
(Fig. 4, d and f). Likewise, wild-type and Justy pre-pro–B cells  Figure 4.  Justy B cell progenitors lack  
B cell potential but retain myeloid and T cell 
potential. (a and b) Flow cytometric analysis 
of cells harvested 10 d after adding 2,000 pre-
pro–B cells (a) or early pro–B cells (b) in media 
containing SCF, Flt3L, and IL-7 to S17 stromal 
cell monolayers. (c) Yields of CD19+B220+ cells 
from cultures started with pre-pro–B or early 
pro–B cells as indicated below the graph.  
(d) Flow cytometric analysis of non–B cells in 
the CD19loB220lo gates in a. (e) Flow cytometric 
analysis of cells obtained 15 d after adding 
2,000 pre-pro–B cells in media containing  
IL-6, -7, and -15 and Flt3L to OP9-DL1 stromal 
cell monolayers. All Thy1.2+CD49b+ cells  
expressed CD25 (not depicted). (f) Yields of cells 
obtained after plating pre-pro–B cells onto the 
indicated stromal cells. All data are representa-
tive of three independent experiments.JEM VOL. 207, July 5, 2010  1363
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into the open reading frame. However, the encoded protein 
was not detected when Justy cell lysates were immuno-
blotted with antibodies capable of recognizing it (unpub-
lished data). This result suggests that inclusion of the 81-nt 
sequence, and thus the premature termination codons, acti-
vates the nonsense-mediated decay RNA surveillance path-
way (Chang et al., 2007), preventing translation of the 
encoded protein.
Aberrant splicing of Gon4l RNA results in decreased 
expression of protein
It was not feasible to assess how the mutation affects Gon4l 
protein expression in the few B-lineage cells present in Justy 
mice. However, Northern blot analysis showed that Gon4l 
RNA was abundant in wild-type and Justy thymocytes (un-
published data). Immunoblotting of thymocyte lysates with 
antibodies specific for the C terminus of Gon4l showed that 
wild-type cells express this protein and that the level of Gon4l 
in Justy cells was greatly reduced (Fig. 5 e). To correlate this 
effect with altered Gon4l RNA splicing, Q RT-PCR analysis 
of thymocyte RNA was performed using primer pairs specific for 
either aberrantly spliced Gon4l RNA (i.e., containing the 81-nt 
insertion) or for wild-type Gon4l RNA (Fig. 5 f). Aberrantly 
but the amount obtained was generally lower. In addition, 
PCR amplification of Justy cDNA gave rise to a prominent 
and unique 527-bp product that contained an 81-bp sequence 
inserted between exons 24 and 25. BLAT analysis (UCSC 
Genome  Browser)  showed  that  the  insertion  was  derived 
from  the  intron  between  Gon4l  exons  24  and  25.  Gon4l 
mRNA  containing  the  insertion  was  otherwise  unaffected 
based  on  sequence  analysis  of  PCR  products  anchored  to   
the insertion.
The data described in the previous paragraph posited that 
intron 24 of Gon4l in Justy mice contains a mutation that 
causes the 81-bp element to be recognized as an exon. Se-
quence analysis of the Justy genome identified a T-to-A sub-
stitution  immediately  downstream  of  the  81-nt  sequence 
that increases homology between the adjoining region and 
the consensus donor pre-mRNA splice site (Fig. 5 d). The 
structure of the 527-bp Justy-specific PCR product con-
firmed that this region is used as a donor splice site, resulting 
in fusion of the 81-nt sequence to exon 25. The structure of 
the 527-bp product also showed that a cryptic acceptor splice 
site in intron 24 mediates fusion of the 81-nt sequence to 
exon  24.  Notably,  inclusion  of  the  81-nt  sequence  into 
Gon4l  mRNA  places  two  premature  termination  codons 
Figure 5.  The Justy mutation disrupts synthesis of 
RNA and protein from the Gon4l gene. (a) Schematic 
showing the region of mouse chromosome 3 containing 
the Justy mutation. (b) Q RT-PCR analysis of gene expres-
sion in lineage-negative bone marrow cells. Three inde-
pendent sets of wild-type and Justy cells were analyzed 
and values for each RNA were normalized to that for 
Hprt. Ratios between Justy and wild-type values (Justy/
WT) were calculated for all RNAs. Shown are the ratio 
means and standard deviations from the three sets.  
(c) Schematic (top) of a portion of the Gon4l gene and 
the primers used for RT-PCR. The red asterisk denotes  
the Justy mutation. The black box represents the 81-bp  
insertion found in the 527-bp Justy-specific PCR prod-
uct. Agarose gel (center) shows products from PCR am-
plification of cDNA from the indicated organs. BM, bone  
marrow. Structures of the Gon4l products seen are dia-
grammed (bottom). Hprt cDNA amplification indicated 
that all samples contained similar amounts of total 
cDNA. (d) Schematic shows that the Justy mutation  
(labeled) increases homology to the consensus donor 
splice site sequence. The same region from wild-type 
Gon4l is shown. Red ovals denote matches to the con-
sensus splice site sequence. (e) Immunoblot of thymocyte 
lysates using Gon4l antibodies. Immunoblot for -actin 
confirmed equal protein loading. Lysates from 293T cells 
transfected with a Gon4l expression plasmid (+) or empty 
vector () were used as controls. (f) Q RT-PCR analysis of 
aberrantly spliced and wild-type forms of Gon4l RNA in 
thymocytes. Diagrams at the top show the location of 
the PCR primers used relative to the Gon4l cDNA that 
was amplified. In the left graph, the wild-type value is 
relative to the Justy value, which was set at 1. In the 
right graph, the Justy value is relative to the wild-type value, which was set at 1. Error bars indicate standard error of the mean. All data are representa-
tive of three independent experiments.1364 Gon4l is required for B lymphopoiesis | Lu et al.
development of pro–B cells requires the transcription factors 
E2A, EBF, and Pax5. Justy pre-pro–B and early pro–B cells 
expressed normal levels of RNA encoding these factors, ex-
cept that the level of Pax5 RNA in Justy early pro–B cells was 
consistently but modestly elevated (Fig. 6 e). Consistent with 
these data, Justy cells expressed normal or slightly decreased 
levels of RNA encoding other B-lineage factors (Fig. S4). 
spliced RNA was detected in Justy cells but not in wild type. 
Wild-type Gon4l RNA was observed in both wild-type and 
Justy  thymocytes  but  the  level  in  Justy  cells  was  10-fold 
lower. These data demonstrate that disruption of Gon4l RNA 
splicing as a result of the Justy mutation greatly reduces expres-
sion of wild-type Gon4l mRNA and thus protein.
Wild-type Gon4l RNA levels are greatly decreased in Justy  
B cell progenitors
Gon4l expression in B cell progenitors was assessed. Q RT-PCR 
analysis showed that Gon4l RNA is present at all stages of   
B lymphopoiesis and at elevated levels in later stages (Fig. 6 a). 
Immunoblot analysis of lysates prepared from wild-type pro–B 
cells grown in culture demonstrated that Gon4l was present 
(Fig. 6 b), which is consistent with the Justy phenotype. Gon4l 
was also detected in lysates from the mouse B cell line M12 
(Fig. 6 b) or those from other mouse B cell lines (not depicted). 
Q RT-PCR analysis was performed to determine the levels of 
wild-type and aberrantly spliced Gon4l RNA in sort-purified 
pre-pro–B and early pro–B cells (Fig. 6 c). Similar to thymo-
cytes, aberrantly spliced Gon4l RNA was detected only in 
Justy B cell progenitors. Wild-type Gon4l RNA was detected 
in both wild-type and Justy cells but the levels in Justy cells 
were greatly and significantly reduced. These data show that 
the Justy mutation dramatically reduces expression of wild-type 
Gon4l mRNA in B cell progenitors, an effect which was dem-
onstrated to decrease Gon4l protein expression.
Gon4l encodes a protein with homology  
to transcriptional corepressors
As described for its orthologues (Liu et al., 2007; Ohtomo   
et al., 2007), mouse Gon4l contains regions with homology to 
transcriptional regulators (Fig. 6 d). A portion of Gon4l is 78% 
similar to human YY1AP (YY1-associated protein), so named 
because it interacts with the transcription factor YY1 (Wang   
et al., 2004). Two regions near the C terminus of Gon4l bear 
strong homology (E-values of 2.2 and 3.4 × 1012; from the 
SMART database) to the consensus paired amphipathic helix 
(PAH) repeat sequence, which forms a four-helix bundle 
(Brubaker et al., 2000). The mammalian transcriptional co-
repressors  Sin3a  and  Sin3b  each  contain  four  PAH  repeats, 
which mediate interactions with chromatin-modifying factors 
or DNA-binding proteins (Grzenda et al., 2009). NMR analysis 
(protein data bank accession code 1UG2) has shown that the   
C terminus of Gon4l forms a helix-loop-helix structure called 
a SANT domain (SWI3, ADA2, N-CoR, and TFIIIB; Boyer 
et al., 2004). Proteins containing this domain include the co-
repressor proteins SMRT and N-CoR. Lastly, the zebrafish and 
C. elegans Gon4l proteins can localize to the nucleus (Friedman 
et al., 2000; Liu et al., 2007). These features implicate Gon4l in 
pathways that mediate transcriptional regulation.
Regulation of gene expression is altered  
in Justy B cell progenitors
Q RT-PCR analysis was performed to assess how the Justy 
mutation affects gene expression in B cell progenitors. The 
Figure 6.  Decreased expression of Gon4l impairs gene repression 
in B cell progenitors. (a) Q RT-PCR analysis of Gon4l RNA in B cell frac-
tions. PCR primers used targeted exon 33 and the 3 UTR of Gon4l RNA. 
Values shown are normalized to Hprt values. (b) Immunoblot of wild-type 
pro–B cell lysate probed with Gon4l antibodies. Asterisk denotes full-
length Gon4l. Generation of pro–B cells is described in Materials and 
methods. Lysate from the mouse B cell line M12 was included as a con-
trol. Probing for GAPDH confirmed equal protein loading. (c) Q RT-PCR 
analysis of aberrantly spliced and wild-type forms of Gon4l RNA in B cell 
progenitors. PCR primer pairs shown in Fig. 5 f were used for amplifica-
tion. For the left graph, each value is relative to the Justy pre-pro–B cell 
value, which was set at 1. For the right graph, each value is relative to the 
wild-type pre-pro–B cell value, which was set at 1. (d) Schematic of the 
Gon4l protein. Structural motifs noted are described in the text. (e) Q RT-
PCR analysis of RNA encoding the indicated proteins in B cell progenitors. 
For all RNAs, values are plotted relative to the wild-type pre-pro–B cell 
value, which was set at 1. (f) Q RT-PCR analysis of the indicated RNAs in 
early pro–B cells. Each Justy value is relative to the wild-type value, which 
was set at 1. All data are representative of three independent experi-
ments. Error bars indicate standard error of the mean.JEM VOL. 207, July 5, 2010  1365
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RNA levels in tissues from wild-type and Justy mice showed 
that such variation occurs (Fig. S5). These data suggest the Justy 
mutation has created a conditional loss-of-function Gon4l  
allele  rather  than  a  completely  nonfunctional  one.  Further 
analysis of Justy mice and the Gon4l protein will address these 
issues and will likely yield novel insights regarding mechanisms 
that regulate B lymphopoiesis.
MATERIALS AND METHODS
Mice. Mutagenesis, breeding, and positional cloning have been previously 
described (Hrabé de Angelis et al., 2000; Augustin et al., 2005). Mice were 
used in compliance with the United States Department of Health and Human 
Services Guide for Use of Laboratory Animals, as documented in writing and 
approved by the University of Iowa Animal Care and Use Committee.
Bone marrow transplantation. Recipients were given 1,100 rads of irra-
diation. 1 h later, 107 red blood cell–depleted bone marrow cells were in-
jected into the retro-orbital plexus. Recipients were given drinking water 
containing antibiotic (Baytril) for 3 wk afterward and analyzed 5 wk later.
Flow cytometric analysis and cell sorting. Cells were suspended in PBS 
containing 3% FBS and preincubated with anti-CD16/32. Cells were incu-
bated with fluorochrome- or biotin-conjugated antibodies for 30 min on ice 
and washed. When necessary, cells were resuspended in buffer containing 
streptavidin- or avidin-conjugated fluorophore, incubated for 30 min on ice, 
and washed. Flow cytometric analysis was performed using an LSR II or   
a FACSDiva (BD) and data were analyzed using FlowJo (Tree Star, Inc.).   
A FACSDiva was used to sort purify cells. To isolate cells at the pre–B cell 
stage onward, splenocytes or bone marrow cells were stained and sorted. To 
isolate pre-pro–B and early pro–B cells from bone marrow, a negative selec-
tion step was included. Cells were incubated with rat anti–mouse Ter-119, 
CD5, Ly6C, and IgM, washed, and then incubated with magnetic beads 
coated with sheep anti–rat antibodies (Invitrogen). Beads and bound cells were 
removed and remaining cells were stained and sorted. Intracellular staining for 
phospho-Stat5 was performed using a PE-labeled mouse anti–phospho-Stat5 
antibody according to the manufacturer’s (BD) instructions.
Antibodies. The following fluorochrome-conjugated antibodies were pur-
chased from the listed sources or generated in the Waldschmidt Laboratory: 
Alexa Fluor 700-B220 (RA3-6B2), APC-c-Kit (2B8), and APC-CD24/HSA 
(M1/69; BioLegend); Sca-1 (D7; Pacific Blue); APC conjugates B220 (RA3-
6B2) and CD3 (145-2C11), FITC conjugates CD11c (N418) and CD49b 
(DX5), PE conjugates BP-1 (6C3) and CD25 (PC61.5), and PE-Cy7 conju-
gates CD11c (N418) and CD19 (1D3; eBioscience); APC-Thy-1.2 (53–2.1), 
APC-Cy7-B220 (RA3-6B2), PE-Gr-1 (RB6-8C5), and PerCP-B220 (RA3-
6B2)  and  Biotin  conjugates  CD11b/Mac-1  (M1/70),  Gr-1  (RB6-8C5), 
CD43 (S7), CD49b (DX5), CD11c (N418), Ter-119, CD3 (145-2C11), and 
CD19 (APC-H7; BD); Avidin-Texas Red and Streptavidin Per-CP (BD); 
Streptavidin Qdot 605 (Invitrogen); FITC-Ly6d (RGRSL 114.8.1; Sigma-
Aldrich); Cy5-, FITC-, PE- and PE-Cy7-B220 (RA3-6B2) and FITC-CD3 
(145-2C11),  Texas  Red-CD45.1  (A20),  FITC-CD45.2  (104),  PE-CD4 
(GK1.5), Cy5-CD8 (53–6.7), FITC-CD21 (7E9), PE-CD23 (B3B4), Cy5-IgM 
(B76), and FITC-Ly6C (Waldschmidt Laboratory).
Stromal cell co-cultures. To test for B and myeloid potential, 2,000 sorted 
cells were added to 24-well plates containing S17 stromal cells (Collins and 
Dorshkind, 1987) in media containing SCF, Flt3L, and IL-7 at 10 ng/ml 
each. To test for T/NK cell potential, 2,000 sorted cells were added to wells 
containing OP9-DL1 stromal cells (Schmitt and Zúñiga-Pflücker, 2002) in 
media containing 1 ng/ml IL-6, 10 ng/ml IL-7, 10 ng/ml Flt3L, and 25 ng/ml 
IL-15. 10 or 15 d later, cells were harvested and analyzed by flow cytometry. 
S17  cultures  were  stained  for  Ly6C,  Gr-1,  CD11b,  B220,  and  CD19;   
OP9-DL1 cultures were stained for Thy-1.2, CD25, CD49b (DX5), B220, 
and CD19.
These findings suggest that decreased expression of E2A, EBF, 
or Pax5 is not responsible for the phenotype.
Progression of B lymphopoiesis has been correlated with 
decreased expression of RNA encoding PU.1 or C/EBP 
(Rumfelt et al., 2006). Either of these transcription factors in-
hibits B lymphopoiesis when expressed at inappropriately high 
levels (DeKoter and Singh, 2000; Heavey et al., 2003; Xie et al., 
2004; Hsu et al., 2006). As reported previously (Rumfelt et al., 
2006), Q RT-PCR analysis of wild-type cells suggested that 
expression of PU.1 and C/EBP RNA is down-regulated 
during the pre-pro–B to early pro–B cell transition (by factors 
of 4 and 46, respectively; unpublished data). In Justy pre-
pro–B cells, the level of PU.1 RNA was slightly increased 
(1.4-fold), whereas that of C/EBP RNA was significantly 
elevated (3.5-fold; P < 0.025) relative to that detected in 
wild-type cells. In Justy early pro–B cells, the levels of PU.1 
and C/EBP RNA were both significantly higher than those 
in wild-type cells, with the latter being increased by a factor of 
20 (Fig. 6 f). Furthermore, comparison of Q RT-PCR data 
from Justy pre-pro–B and early pro–B cells suggested that 
mechanisms that down-regulate PU.1 and C/EBP RNA 
expression are impaired. Consistent with these abnormalities, 
RNA encoded by the PU.1 and C/EBP target gene Csf1r 
was expressed at elevated levels in Justy early pro–B cells relative 
to wild type (Fig. 6 f). These results suggest that loss of Gon4l 
expression impairs pathways that inhibit expression of PU.1 
and C/EBP RNA in developing B cells.
Gon4l orthologues are present in the genomes of plants, 
invertebrates, and vertebrates (Kuryshev et al., 2006) and is 
highly conserved among the latter. Similar to our study, for-
ward-genetic studies involving C. elegans and zebrafish have 
demonstrated that Gon4l is important for specific develop-
mental pathways (Friedman et al., 2000; Liu et al., 2007). 
Homozygosity for loss-of-function Gon4l alleles in zebrafish 
cause embryologic abnormalities and death soon after con-
ception (Liu et al., 2007). Furthermore, such mutations dis-
rupt erythropoiesis and the expression of key erythroid genes 
(Liu et al., 2007), suggesting that Gon4l is required for hema-
topoietic development. In addition, loss of Gon4l expression 
in zebrafish appears to affect pathways that control cell cycle 
progression (Liu et al., 2007; Lim et al., 2009). Ours is the 
first study to demonstrate that Gon4l has an important role in 
mammalian hematopoiesis.
Gon4l RNA is expressed throughout zebrafish embryos 
(Liu et al., 2007) and is broadly expressed in mammals (Kuryshev 
et al., 2006; Ohtomo et al., 2007, 2008). Our data show that 
Gon4l RNA and protein are expressed in B-lineage cells and 
thymocytes, indicating that Gon4l is not a B-lineage–specific 
factor. Why the Justy mutation seems to affect only B lympho-
poiesis is not clear. Perhaps the role of Gon4l varies between 
cell lineages and tissues, which suggests that additional but sub-
tler phenotypes might exist. Another factor that may contrib-
ute to the specificity of the phenotype is variation between 
tissues in the extent of aberrant Gon4l pre-mRNA splicing 
and, thus, the decrease in wild-type Gon4l RNA and protein 
expression. Indeed, Q RT-PCR analysis of wild-type Gon4l 1366 Gon4l is required for B lymphopoiesis | Lu et al.
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Pro–B cells were generated by adding Lin cells to layers of OP9 stro-
mal cells in media containing SCF, Flt3L, and IL-7 at 10 ng/ml each. Lin 
cells were isolated by negative selection (as described in the Flow cytometric 
analysis and cell sorting section) except that antibodies for CD19 and B220 
were included. Cultures were started in 24-well plates and expanded over a 
3-wk period. > 90% of the cells obtained were B220+CD19+.
RT-PCR  analysis.  RNA  was  isolated  using  TRIzol  (Invitrogen)  and   
reverse transcribed using SuperScript III (Invitrogen). Conventional PCR 
was performed using AmpliTaq Gold (Applied Biosystems) and a MyCycler 
(Bio-Rad Laboratories). Quantitative real-time PCR was performed using 
POWER SYBR Green Master Mix and the PRISM 7700 Detection system 
(Applied Biosystems) to obtain cycle threshold (Ct) values for target and in-
ternal reference (Hprt) cDNAs. Target cDNA levels were normalized to Hprt 
cDNA levels using the Eq. 2[Ct], where Ct is defined as Cttarget  CtHprt.
Antibody  production  and  immunoblot  analysis.  cDNA  encoding 
Gon4l aa 938–1364 or 1746–2260 was cloned into the plasmid pGEX-5-1 
(GE Healthcare). GST-Gon4l fusion proteins were expressed in bacteria and 
purified using glutathione-agarose beads. Fusion proteins were cleaved with 
Factor Xa (GE Healthcare) and resolved by SDS-PAGE. Rabbits were im-
munized three to five times with gel slices containing Gon4l protein. Immu-
noglobulins from pooled bleeds were purified by protein A–Sepharose and 
affinity selection and used for immunoblot analysis. Protein lysates were pre-
pared by resuspending cells in RIPA buffer containing protease inhibitors 
(Roche). Immunoblot analysis used standard protocols.
Online supplemental material. Fig. S1 shows flow cytometric analysis and 
quantification of hematopoietic and myeloid progenitors in bone marrow. 
Fig. S2 shows flow cytometric analysis and quantification of CLPs in bone 
marrow. Fig. S3 shows flow cytometric analysis of IL-7R expression and 
phospho-Stat5 levels in B cell progenitors. Fig. S4 shows Q RT-PCR analysis 
of B lineage gene expression in B cell progenitors. Fig. S5 shows the ratio of 
normal Gon4l RNA detected in tissues from Justy or wild-type mice as de-
termined by Q RT-PCR analysis. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20100147/DC1.
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